Novel therapies in osteoporosis – Clinical update – 2025
- 25 September 2025
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 39 (4) , 102100
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorptionJournal of Cellular Physiology, 2023
- Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort StudyJBMR Plus, 2022
- Tiliroside is a new potential therapeutic drug for osteoporosis in miceJournal of Cellular Physiology, 2019
- Bone morphogenetic protein receptor signal transduction in human diseaseThe Journal of Pathology, 2018
- FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabJournal of Bone and Mineral Research, 2018
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With OsteoporosisJAMA, 2016
- A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAXJournal of Bone and Mineral Research, 2015
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral DensityJournal of Bone and Mineral Research, 2014
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2013
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosisJournal of Bone and Mineral Research, 2010